当代帕金森病的生存率增加:一项为期47年的解剖研究
Eric Noyes1, Ali H Rajput1, Minyoung Kim2
1Saskatchewan Movement Disorders Program, Division of Neurology, Department of Medicine, University of Saskatchewan/Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
Neuroepidemiology
|November 14, 2024
概括
在70岁以下的患者中,Levodopa治疗显著增加了帕金森病 (PD) 存活率. 现代PD护理带来了新的挑战,因为寿命更长,患者复杂性增加.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,主要症状包括勃拉迪基尼西亚,刚性和震.
- 利沃多巴 (LD) 自20世纪60年代以来一直是PD的主要治疗方法,影响了患者的生存率和神经流行病学.
- 预期寿命的增加导致了PD风险人口的增加,发病年龄是生存的关键因素.
研究的目的:
- 为了评估尸检确认的帕金森病患者的生存率,这些患者在70岁之前就开始了帕金森病,接受了利沃多巴治疗.
- 为了比较生存结果与类似的PD病例,这些病例是在乐伏多巴广泛可用之前被诊断出来的.
主要方法:
- 分析了萨斯喀彻温州运动障碍计划 (SMDP) 47年 (1968-2015) 的数据.
- 包括尸检确认的帕金森病患者和70岁以下的发病年龄.
- 莱沃多巴治疗和莱沃多巴治疗前队列之间的生存数据的比较.
主要成果:
- 这项研究包括128例70岁前发病的帕金森病病例.
- 70岁以下的勒沃多巴治疗PD患者的中位生存时间为18年.
- 在服用莱沃多巴前,70岁以下的PD患者的平均存活时间为9.4年.
结论:
- 现代的利沃多巴治疗已经大大提高了帕金森病患者的生存率.
- 增加的生存率带来了挑战,包括越来越多的老年人,慢性治疗患者和复杂的并发病.
- 帕金森病的不断变化的景观需要一个更大,更多样化的劳动力,用于患者护理和研究.
更多相关视频
10:37A Gravity-Fed Transcardial Perfusion Method for Histologic Analysis of the Mouse Central Nervous System
Published on: January 21, 2022
8.7K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.4K
相关概念视频
01:24Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:20Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328